Moore Kerryn A, Simpson Julie A, Wiladphaingern Jacher, Min Aung Myat, Pimanpanarak Mupawjay, Paw Moo Kho, Raksuansak Jathee, Pukrittayakamee Sasithon, Fowkes Freya J I, White Nicholas J, Nosten François, McGready Rose
Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.
Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, VIC, Australia.
BMC Med. 2017 Jun 21;15(1):117. doi: 10.1186/s12916-017-0877-6.
Most evidence on the association between malaria in pregnancy and adverse pregnancy outcomes focuses on falciparum malaria detected at birth. We assessed the association between the number and timing of falciparum and vivax malaria episodes during pregnancy on small-for-gestational-age (SGA) and preterm birth.
We analysed observational data collected from antenatal clinics on the Thailand-Myanmar border (1986-2015). We assessed the effects of the total number of malaria episodes in pregnancy on SGA and the effects of malaria in pregnancy on SGA, very preterm birth, and late preterm birth, by the gestational age at malaria detection and treatment using logistic regression models with time-dependent malaria variables (monthly intervals). World Health Organisation definitions of very preterm birth (≥28 and <32 weeks) and late preterm birth (≥32 and <37 weeks) and international SGA standards were used.
Of 50,060 pregnant women followed, 8221 (16%) had malaria during their pregnancy. Of the 50,060 newborns, 10,005 (21%) were SGA, 540 (1%) were very preterm, and 4331 (9%) were late preterm. The rates of falciparum and vivax malaria were highest at 6 and 5 weeks' gestation, respectively. The odds of SGA increased linearly by 1.13-fold (95% confidence interval: 1.09, 1.17) and 1.27-fold (1.21, 1.33) per episode of falciparum and vivax malaria, respectively. Falciparum malaria at any gestation period after 12-16 weeks and vivax malaria after 20-24 weeks were associated with SGA (falciparum odds ratio, OR range: 1.15-1.63 [p range: <0.001-0.094]; vivax OR range: 1.12-1.54 [p range: <0.001-0.138]). Falciparum malaria at any gestation period after 24-28 weeks was associated with either very or late preterm birth (OR range: 1.44-2.53; p range: <0.001-0.001). Vivax malaria at 24-28 weeks was associated with very preterm birth (OR: 1.79 [1.11, 2.90]), and vivax malaria at 28-32 weeks was associated with late preterm birth (OR: 1.23 [1.01, 1.50]). Many of these associations held for asymptomatic malaria.
Protection against malaria should be started as early as possible in pregnancy. Malaria control and elimination efforts in the general population can avert the adverse consequences associated with treated asymptomatic malaria in pregnancy.
大多数关于孕期疟疾与不良妊娠结局之间关联的证据都集中在出生时检测到的恶性疟。我们评估了孕期恶性疟和间日疟发作的次数及时间与小于胎龄儿(SGA)和早产之间的关联。
我们分析了从泰国 - 缅甸边境产前诊所收集的观察性数据(1986 - 2015年)。我们使用具有时间依赖性疟疾变量(每月间隔)的逻辑回归模型,通过疟疾检测和治疗时的孕周,评估孕期疟疾发作总数对SGA的影响以及孕期疟疾对SGA、极早产和晚期早产的影响。采用了世界卫生组织对极早产(≥28周且<32周)和晚期早产(≥32周且<37周)的定义以及国际SGA标准。
在随访的50,060名孕妇中,8221名(16%)在孕期患疟疾。在50,060名新生儿中,10,005名(21%)为SGA,540名(1%)为极早产,4331名(9%)为晚期早产。恶性疟和间日疟的发病率分别在妊娠6周和5周时最高。每发作一次恶性疟和间日疟,SGA的几率分别线性增加1.13倍(95%置信区间:1.09,1.17)和1.27倍(1.21,1.33)。12 - 16周后的任何孕周的恶性疟和20 - 24周后的间日疟与SGA相关(恶性疟优势比,OR范围:1.15 - 1.63 [p范围:<0.001 - 0.094];间日疟OR范围:1.12 - 1.54 [p范围:<0.001 - 0.138])。24 - 28周后的任何孕周的恶性疟与极早产或晚期早产相关(OR范围:1.44 - 2.53;p范围:<0.001 - 0.001)。24 - 28周的间日疟与极早产相关(OR:1.79 [1.11,2.90]),28 - 32周的间日疟与晚期早产相关(OR:1.23 [1.01,1.50])。这些关联中的许多在无症状疟疾中也成立。
孕期应尽早开始预防疟疾。普通人群中的疟疾控制和消除努力可以避免与孕期治疗的无症状疟疾相关的不良后果。